ETFWorld: Lyxor launches a new ETF on the London Stock Exchange

The new Lyxor Scientific Beta Developed Long/Short UCITS ETF – USD-Acc is a UCITS compliant exchange traded fund aiming to provide exposure to the Scientific Beta Multi-Beta Multi-Strategy Managed Volatility L/S Equity Market Neutral (x 3.5) Index (TR-USD). …

The index aims to generate absolute performance with limited volatility and low correlation with the broad equity market.

The performance is achieved through a long leg exposed to six factors (Size, Value, Momentum, Low Volatility, Profitability and Investment), a short leg exposed to a broad market cap weighted reference index, and a minimisation of the overall beta to the equity market.

The strategy includes embedded leverage, which amplifies the upward and downward movement in the value of the underlying exposure.

Lyxor Scientific Beta Developed Long/Short UCITS ETF – USD-Acc

ISIN LU1810006780


Base currency USD

Total Expense Ratio 0.55 %

Dividend Treatment Capitalisation

Inception Date 26/04/2018

Replication Method Indirect (Swap Based)

Minimum investment 1 Share

Source: ETFWorld

Related Articles

Global Palladium Fund lists world’s only physically backed copper and nickel ETCs

Editorial Staff

US Global Investors : Europe’s first global airlines ETF to list on London Stock Exchange

Editorial Staff

Amundi : Signature of the master agreement for the acquisition of Lyxor

Editorial Staff